LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1

55 filings reported holding 53220KAF5 - LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 as of Q3 2020.
LIGAND PHARMACEUTICALS INC - NOTE 0.750% 5/1 has 47 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of $505,163,049 of principal .
Largest 10 bondholders include STEELHEAD PARTNERS LLC ($64,562,000 of principal), CANYON CAPITAL ADVISORS LLC ($60,000,000 of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($56,178,000 of principal), UBS ASSET MANAGEMENT AMERICAS INC ($37,600,000 of principal), WOLVERINE ASSET MANAGEMENT LLC ($30,073,000 of principal), Davidson Kempner Capital Management LP ($22,500,000 of principal), LAZARD ASSET MANAGEMENT LLC ($20,928,000 of principal), OAKTREE CAPITAL MANAGEMENT LP ($18,629,000 of principal), Nuveen Asset Management, LLC ($17,025,000 of principal), and GOLDMAN SACHS GROUP INC ($15,394,000 of principal).
This table shows the top 47 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.